Schizophrenia: all 3,539 studies

Page 17 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.

• Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory BeliefsCompletedNCT04748679Not applicable
• A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.TerminatedNCT04742413
• Salutogenic Approach Based Interview With People With SchizophreniaCompletedNCT04740944Not applicable
• rTMS on Appetite and Cognitive Function in SchizophreniaStatus unknownNCT04714970Not applicable
• A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of SchizophreniaCompletedNCT04712734Phase 1
• Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With SchizophreniaCompletedNCT04709224Phase 1
• Effect of Hot Footbath on the Sleep QualityCompletedNCT04703530Not applicable
• CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for SchizophreniaStatus unknownNCT04700930Not applicable
• Social Cognition in Youth Who Have a First Degree Relative With SchizophreniaCompletedNCT04681807Not applicable
• Personalizing Interventions Using Real-World InteractionsCompletedNCT04665401Not applicable
• A Register Study of Effects Following Local Variation in Rates of Involuntary CareCompletedNCT04655287
• "Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"Status unknownNCT04641780
• Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in SchizophreniaCompletedNCT04637724Not applicable
• Level of Immersion of Virtual Reality and Cognition and Motor Performance in Patients of Schizophrenia Spectrum DisorderCompletedNCT04629898Not applicable
• Efficacy and Mechanisms of Low-intensity Focused Ultrasound on Negative Symptoms in Patients With SchizophreniaStatus unknownNCT04620460Not applicable
• Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA)CompletedNCT04618250Not applicable
• Self-Determination Theory and Motivational InterviewingCompletedNCT04611737Not applicable
• Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental StudyCompletedNCT04605393Not applicable
• Ecologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in Patients With Schizophrenia and DepressionCompletedNCT04598906Not applicable
• Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education ProgramsCompletedNCT04590300Not applicable
• Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)Active, not recruitingNCT04589208Phase 1/2
• Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy VolunteersCompletedNCT04588129Phase 1
• Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum DisorderCompletedNCT04578756Phase 3
• RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal HallucinationsCompletedNCT04578314Not applicable
• Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia PatientsCompletedNCT04572685Phase 1
• Diagnostic Announcement to Relatives of Patients With SchizophreniaStatus unknownNCT04562961Not applicable
• Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory ProcessingCompletedNCT04554121Not applicable
• Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia PatientsStatus unknownNCT04553835Not applicable
• Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental IllnessStatus unknownNCT04551027Not applicable
• Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of SchizophreniaCompletedNCT04545294Not applicable
• Effectiveness of a Nurse Facilitated Face Care Group in Patients With SchizophreniaCompletedNCT04542928Not applicable
• Study on the Gut Microbial Mechanism of Negative Symptoms of SchizophreniaStatus unknownNCT04533724Early Phase 1
• SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant SchizophreniaStatus unknownNCT04528095Phase 3
• A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia PatientsCompletedNCT04521868Phase 2
• Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine LearningStatus unknownNCT04520399
• Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic SyndromeSuspendedNCT04518319Phase 2
• Research on Accurate Prediction of Long-term Medication Use for Schizophrenia Based on Cognitive FunctionStatus unknownNCT04513275
• The Effectiveness of Assertive Community Treatment on Schizophrenic PatientsCompletedNCT04511663Not applicable
• A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With SchizophreniaCompletedNCT04510298Phase 1
• Efficacy of Chronic Disease Self-management Program in People With SchizophreniaCompletedNCT04503954Not applicable
• Academic-Community EPINET (AC-EPINET)CompletedNCT04497857Not applicable
• The Motor Neurological Soft Signs (MNSS) in Persons With SchizophreniaCompletedNCT04495998Not applicable
• Peer-delivered and Technology-Assisted Integrated Illness Management and RecoveryCompletedNCT04481737Not applicable
• Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in SchizophreniaStatus unknownNCT04481217Not applicable
• Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance SchizophreniaStatus unknownNCT04478032Not applicable
• Animal-Assisted Therapy in Patients With SchizophreniaStatus unknownNCT04476836Not applicable
• Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic SchizophreniaCompletedNCT04461119Phase 2
• Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model BuildingStatus unknownNCT04446234Phase 4
• Self and Body-esteem in Socio-professional RehabilitationCompletedNCT04436757Not applicable
• The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia PatientsCompletedNCT04432688
• Lifestyle Redesign For SchizophreniaStatus unknownNCT04430868Not applicable
• Baduanjin on Patients With SchizophreniaCompletedNCT04430309Not applicable
• Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum DisordersCompletedNCT04418011Not applicable
• Effects of 12 Weeks Walking on Cognitive Function in SchizophreniaCompletedNCT04411979Not applicable
• Impact of Stigma in Siblings of Young Patients With Schizophrenic DisordersStatus unknownNCT04411797
• Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of HallucinationsStatus unknownNCT04399096
• Assessing a WeChat-based Integrative Family Intervention (WIFI) for SchizophreniaStatus unknownNCT04393896Not applicable
• A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.CompletedNCT04369391Phase 1
• Normobaric Oxygen Therapy for Individuals With First-Episode PsychosisTerminatedNCT04368039Not applicable
• Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic DisordersCompletedNCT04366401Not applicable
• Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in SchizophreniaCompletedNCT04352569Not applicable
• Investigation of Community Reablement on Instrumental Activities of Daily Living in People With SchizophreniaCompletedNCT04350775Not applicable
• Survey on Pre-ECT Evaluation and ECT ApplicationStatus unknownNCT04335916
• Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With SchizophreniaCompletedNCT04325737Phase 1
• Intervention Targeting Motivational Negative SymptomsCompletedNCT04325100Not applicable
• Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental IllnessCompletedNCT04324944Not applicable
• rTMS Add on Value for Amelioration of Negative Symptoms of SchizophreniaActive, not recruitingNCT04318977Not applicable
• Using Clinical Process Indicators, Patient Reported Outcome Measures (PROMs), and Patient Reported Experience Measures (PREMs) to Improve the Quality and Continuity of Care for Psychiatric PatientsStatus unknownNCT04314154
• Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"CompletedNCT04312503
• DEcision-making Capacity: Intervention Development & Evaluation in Schizophrenia-spectrum DisorderStatus unknownNCT04309435Not applicable
• Study of CAD-9303 in Subjects With SchizophreniaCompletedNCT04306146Phase 1
• The Synergistic Effect of Hypoglycemic Index Diet on Refractory SchizophreniaStatus unknownNCT04302636Not applicable
• ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis InterventionCompletedNCT04298450Not applicable
• Antipsychotic Effects of Probiotics and Prebiotics on Patients With SchizophreniaStatus unknownNCT04291469Not applicable
• Psychoeducation in Patients Who Diagnosed With SchizophreniaCompletedNCT04280835Not applicable
• Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-ageCompletedNCT04280367
• Cognitive Remediation Therapy in Schizophrenia: Effects on EpigeneticsStatus unknownNCT04278027Not applicable
• Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia (PRISCA)Status unknownNCT04276012Not applicable
• TMS in Treatment of Schizophrenia Negative SymptomsStatus unknownNCT04268797Not applicable
• Evaluating a Novel Mobile App for Social Cognition in PsychosisCompletedNCT04260763Not applicable
• Therapeutic Effect of Cassia Seed in Obesity of Patients With SchizophreniaCompletedNCT04252131Phase 1
• Verbal Memory Training Using Virtual Reality in SchizophreniaCompletedNCT04251195Not applicable
• Using mHealth to Optimize Pharmacotherapy RegimensCompletedNCT04248517Not applicable
• Mechanistic Clinical Trial of Individualized tDCS for Hallucinations in SchizophreniaWithdrawnNCT04248010Not applicable
• Clinical and Genetic Influencing Factors on Clozapine PharmacokineticsCompletedNCT04240496Not applicable
• Health Outcomes Via Positive Engagement in SchizophreniaActive, not recruitingNCT04230590
• Effects of Transcranial Direct Current Stimulation (tDCS) on Persistent Auditory Verbal Hallucinations in SchizophreniaStatus unknownNCT04222582Not applicable
• Suicide Prevention Intervention for Schizophrenia-Spectrum DisordersCompletedNCT04221269Not applicable
• Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in SchizophreniaCompletedNCT04220099
• Financial Incentives to Improve Medication AdherenceCompletedNCT04191876Not applicable
• Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens HospitalCompletedNCT04191200
• Effect of Intranasal Vasopressin on Cooperative Behavior in SchizophreniaCompletedNCT04190004Not applicable
• Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy AdultsCompletedNCT04187560Phase 1
• Improving Cognition in Schizophrenia Using Non-invasive Brain StimulationCompletedNCT04184830Not applicable
• Neurobiological Effects of Oxytocin in SchizophreniaStatus unknownNCT04177719Not applicable
• Oxytocin and Social Decision Making in SchizophreniaCompletedNCT04176835Not applicable
• Cognitive Remediation Program for Family Caregivers in SchizophreniaStatus unknownNCT04173598Not applicable
• Neurobiological Effects of Oxytocin in Schizophrenia - Imaging StudyCompletedNCT04158167Not applicable
• A Study of Staccato Loxapine (ADASUVE®) for InhalationStatus unknownNCT04148963Phase 3
• Application of a Mindfulness and Self-Compassion Program in Patients With Schizophrenia. Randomized Controlled Trial.Status unknownNCT04144075Not applicable

← Schizophrenia overview